BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhou JH, Cai JJ, She ZG, Li HL. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. World J Gastroenterol 2019; 25(11): 1307-1326 [PMID: 30918425 DOI: 10.3748/wjg.v25.i11.1307]
URL: https://www.wjgnet.com/1948-5182/full/v25/i11/1307.htm
Number Citing Articles
1
Jie Zhang, Jie Tan, Mengke Wang, Yifen Wang, Mengzhen Dong, Xuefeng Ma, Baokai Sun, Shousheng Liu, Zhenzhen Zhao, Lizhen Chen, Kai Liu, Yongning Xin, Likun Zhuang. Lipid-induced DRAM recruits STOM to lysosomes and induces LMP to promote exosome release from hepatocytes in NAFLDScience Advances 2021; 7(45) doi: 10.1126/sciadv.abh1541
2
Hassan M. Heshmati. Advances in Hepatology2021;  doi: 10.5772/intechopen.97568
3
Banrida Wahlang, Savitri Appana, K. Cameron Falkner, Craig J. McClain, Guy Brock, Matthew C. Cave. Insecticide and metal exposures are associated with a surrogate biomarker for non-alcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003–2004Environmental Science and Pollution Research 2020; 27(6): 6476 doi: 10.1007/s11356-019-07066-x
4
Sun Kyung Jeon, Jeong Min Lee, Ijin Joo. Clinical Feasibility of Quantitative Ultrasound Imaging for Suspected Hepatic Steatosis: Intra- and Inter-examiner Reliability and Correlation with Controlled Attenuation ParameterUltrasound in Medicine & Biology 2021; 47(3): 438 doi: 10.1016/j.ultrasmedbio.2020.11.009
5
Evelyn Nunes Goulart da Silva Pereira, Daniela Polessa Paula, Beatriz Peres de Araujo, Maria de Jesus Mendes da Fonseca, Maria de Fátima Haueisen Sander Diniz, Anissa Daliry, Rosane Harter Griep. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil studyWorld Journal of Gastroenterology 2021; 27(29): 4913-4928 doi: 10.3748/wjg.v27.i29.4913
6
D. A. Miles, C. S. Levi, J. Uhanova, S. Cuvelier, K. Hawkins, G. Y. Minuk. Pocket-Sized Versus Conventional Ultrasound for Detecting Fatty Infiltration of the LiverDigestive Diseases and Sciences 2020; 65(1): 82 doi: 10.1007/s10620-019-05752-x
7
Hidekatsu Kuroda, Yudai Fujiwara, Tamami Abe, Tomoaki Nagasawa, Takuma Oguri, Sachiyo Noguchi, Naohisa Kamiyama, Yasuhiro Takikawa, Gianfranco D. Alpini. Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitisPLOS ONE 2021; 16(4): e0249493 doi: 10.1371/journal.pone.0249493
8
D. V. Voronov, M. G. Minina, A. K. Chomaev, I. M. Iljinsky, O. M. Tsirulnikova. Liver steatosis in brain death donorsRussian Journal of Transplantology and Artificial Organs 2021; 23(1): 8 doi: 10.15825/1995-1191-2021-1-8-14
9
Yuting Guo, Juan Chen, Nan Liu, Zheng Liu, Bimin Shi, Hong Sun. Association of Circulating TXNIP Levels with Fatty Liver in Newly Diagnosed Type 2 Diabetes MellitusDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 225 doi: 10.2147/DMSO.S349153
10
Ru Zhang, Minxian Wang, Min Wang, Liuxin Zhang, Yajie Ding, Zongzhe Tang, Zuqiang Fu, Haozhi Fan, Wei Zhang, Jie Wang. Vitamin D Level and Vitamin D Receptor Genetic Variation Were Involved in the Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control StudyFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.648844
11
Dae Ho Lee. Noninvasive Evaluation of Nonalcoholic Fatty Liver DiseaseEndocrinology and Metabolism 2020; 35(2): 243 doi: 10.3803/EnM.2020.35.2.243
12
Vanessa Bullón-Vela, Itziar Abete, Josep A. Tur, Jadwiga Konieczna, Dora Romaguera, Xavier Pintó, Emili Corbella, Miguel A. Martínez-González, Carmen Sayón-Orea, Estefanía Toledo, Dolores Corella, Manuel Macías-Gonzalez, Francisco J. Tinahones, Montserrat Fitó, Ramon Estruch, Emilio Ros, Jordi Salas-Salvadó, Lidia Daimiel, Catalina M. Mascaró, Maria Angeles Zulet, José Alfredo Martínez. Relationship of visceral adipose tissue with surrogate insulin resistance and liver markers in individuals with metabolic syndrome chronic complicationsTherapeutic Advances in Endocrinology and Metabolism 2020; 11: 204201882095829 doi: 10.1177/2042018820958298
13
Dominika Maciejewska, Arleta Drozd, Karolina Skonieczna-Żydecka, Marta Skórka-Majewicz, Karolina Dec, Karolina Jakubczyk, Anna Pilutin, Ewa Stachowska. Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?Molecules 2020; 25(9): 2026 doi: 10.3390/molecules25092026
14
Jiahui Li, Sudhakar Kundapur Venkatesh, Meng Yin. Advances in Magnetic Resonance Elastography of LiverMagnetic Resonance Imaging Clinics of North America 2020; 28(3): 331 doi: 10.1016/j.mric.2020.03.001
15
Ekram W. Abd El-Wahab, Rehab A. Zein El-Abedin, Walid M. Ahmed, Hanan Z. Shatat. Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian SettingThe American Journal of the Medical Sciences 2020; 360(6): 662 doi: 10.1016/j.amjms.2020.06.020
16
Anne Sophie Schou, Jonas Ellegaard Nielsen, Anders Askeland, Malene Møller Jørgensen. Advances in Clinical Chemistry 2020; 99: 1 doi: 10.1016/bs.acc.2020.02.011
17
Xiong‐Zhang Yin, Wei‐Ming Chi, Ling Zhang, Yan‐Qi Su, Zhong‐Yuan Zhang, Cheng‐Bin Xue. Protective effects of Dendrobium candidum Wall ex Lindl. on high‐fat diet‐induced liver damage in mice Journal of Food Biochemistry 2021; 45(4) doi: 10.1111/jfbc.13687
18
Ivana Mikolasevic, Viktor Domislovic, Irena Krznaric-Zrnic, Zeljko Krznaric, Lucija Virovic-Jukic, Sanja Stojsavljevic, Ivica Grgurevic, Sandra Milic, Ivan Vukoja, Petra Puz, Merica Aralica, Goran Hauser. The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver BiopsyMedicina 2022; 58(2): 252 doi: 10.3390/medicina58020252
19
Muhammad Amjad Pervez, Dilshad Ahmed Khan, Atiq Ur Rehman Slehria, Aamir Ijaz. Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trialComplementary Therapies in Medicine 2020; 52: 102494 doi: 10.1016/j.ctim.2020.102494
20
Man Gong, Chengfu Su, Mengzhe Fan, Ping Wang, Bingdi Cui, Zhongyuan Guo, Shaojia Liang, Lianhe Yang, Xiaoqian Liu, Liping Dai, Zhimin Wang. Mechanism by which Eucommia ulmoides leaves Regulate Nonalcoholic fatty liver disease based on system pharmacologyJournal of Ethnopharmacology 2022; 282: 114603 doi: 10.1016/j.jep.2021.114603
21
Xiaomi Du, Natalie DeForest, Amit R. Majithia. Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and OpportunitiesFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.777075
22
Ken M. Chin, Mikel Prieto, Chin K. Cheong, Marcello Di Martino, Benedetto Ielpo, Brian K.P. Goh, Ye X. Koh. Outcomes after curative therapy for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a meta-analysis and review of current literatureHPB 2021; 23(8): 1164 doi: 10.1016/j.hpb.2021.01.009
23
Jinhua Zhang, Kangli Li, Lingling Pan, Fei Teng, Peizhen Zhang, Bingquan Lin, Youwen Yuan, Xueyun Wei, Wenyuan Li, Huijie Zhang. Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional studyBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01721-9
24
Eda Kaya, Alev Bakir, Haluk Tarik Kani, Coskun Ozer Demirtas, Caglayan Keklikkiran, Yusuf Yilmaz. Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver DiseaseGut and Liver 2020; 14(4): 486 doi: 10.5009/gnl19173
25
Yan-Ci Zhao, Guo-Jun Zhao, Ze Chen, Zhi-Gang She, Jingjing Cai, Hongliang Li. Nonalcoholic Fatty Liver DiseaseHypertension 2020; 75(2): 275 doi: 10.1161/HYPERTENSIONAHA.119.13419
26
Abdulrahman ISMAIEL, Daniel-Corneliu LEUCUTA, Stefan-Lucian POPA, Sharmila FAGOONEE, Rinaldo PELLICANO, Ludovico ABENAVOLI, Dan L. DUMITRASCU. Noninvasive biomarkers in predicting nonalcoholic steatohepatitis and assessing liver fibrosis: systematic review and meta-analysisPanminerva Medica 2021; 63(4) doi: 10.23736/S0031-0808.20.04171-3
27
Zixuan Zhang, James L. Thorne, J. Bernadette Moore. Vitamin D and nonalcoholic fatty liver diseaseCurrent Opinion in Clinical Nutrition & Metabolic Care 2019; 22(6): 449 doi: 10.1097/MCO.0000000000000605
28
Tina Linder, Daniel Eppel, Grammata Kotzaeridi, Ingo Rosicky, Gülen Yerlikaya-Schatten, Herbert Kiss, Karen Weißhaupt, Wolfgang Henrich, Latife Bozkurt, Andrea Tura, Michael Roden, Christian S. Göbl. Fatty liver indices and their association with glucose metabolism in pregnancy – An observational cohort studyDiabetes Research and Clinical Practice 2022; 189: 109942 doi: 10.1016/j.diabres.2022.109942
29
Guanjun Liu, Dongmei Wu, Yiyang Wen, Shundong Cang. Immune-associated molecular occurrence and prognosis predictor of hepatocellular carcinoma: an integrated analysis of GEO datasetsBioengineered 2021; 12(1): 5253 doi: 10.1080/21655979.2021.1962147
30
David T. Fetzer, Ivan M. Rosado-Mendez, Michael Wang, Michelle L. Robbin, Arinc Ozturk, Keith A. Wear, Juvenal Ormachea, Timothy A. Stiles, J. Brian Fowlkes, Timothy J. Hall, Anthony E. Samir. Pulse-Echo Quantitative US Biomarkers for Liver Steatosis: Toward Technical StandardizationRadiology 2022;  doi: 10.1148/radiol.212808
31
Bou-Zenn Lin, Tsung-Jung Lin, Chih-Lin Lin, Li-Ying Liao, Ting-An Chang, Buo-Jia Lu, Kuan-Yang Chen. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver diseaseJournal of the Chinese Medical Association 2021;  doi: 10.1097/JCMA.0000000000000530
32
Abdulhakeem S. Alamri, Majid Alhomrani, Walaa F. Alsanie, Ahmad Joman Alghamdi, Zaher M. Alghamdi, Abdualmohsen A. Al-Subaie, Yasser A. Alharthi, Hesham H. Alqurashi, Syed Mohammed Basheeruddin Asdaq. Prevalence and predictors of non-alcoholic fatty liver disease in tertiary care hospital of Taif, Saudi Arabia: A retrospective studySaudi Journal of Biological Sciences 2021; 28(9): 4921 doi: 10.1016/j.sjbs.2021.05.063
33
Menglong Li, Wen Shu, Jiawulan Zunong, Nubiya Amaerjiang, Huidi Xiao, Dan Li, Sten H. Vermund, Yifei Hu. Predictors of non-alcoholic fatty liver disease in childrenPediatric Research 2022; 92(1): 322 doi: 10.1038/s41390-021-01754-6
34
Hai-Jian Sun, Zhi-Yuan Wu, Xiao-Wei Nie, Xin-Yu Wang, Jin-Song Bian. Implications of hydrogen sulfide in liver pathophysiology: Mechanistic insights and therapeutic potentialJournal of Advanced Research 2021; 27: 127 doi: 10.1016/j.jare.2020.05.010
35
Tsung-Hsien Chou, Hsing-Jung Yeh, Chun-Chao Chang, Jui-Hsiang Tang, Wei-Yu Kao, I-Chia Su, Chien-Hung Li, Wei-Hao Chang, Chun-Kai Huang, Herdiantri Sufriyana, Emily Chia-Yu Su. Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liverJournal of the Chinese Medical Association 2021; 84(9): 842 doi: 10.1097/JCMA.0000000000000585
36
Xia Wang, Weiqin Li, Jiangfeng Fu, Yaping Ni, Kaige Liu, Fenglin Liu. Correlation between T-Lymphocyte Subsets, Regulatory T Cells, and Hepatic Fibrosis in Patients with Nonalcoholic Fatty LiverEvidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/6250751
37
Yuping Zeng, He He, Zhenmei An, Jin Chai. Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver DiseaseDisease Markers 2022; 2022: 1 doi: 10.1155/2022/1254014
38
Marton Fekete, Marton Piroska, Marcell Szily, Mercedesz Erdei, Zsofia Jokkel, Helga Szabo, Levente Littvay, Gyorgy Baffy, Adam Domonkos Tarnoki, David Laszlo Tarnoki. Heritability analysis of liver stiffness detected by ultrasound shear wave elastography: a twin studyEuropean Journal of Gastroenterology & Hepatology 2021; 33(1S): e766 doi: 10.1097/MEG.0000000000002246
39
Feng Gao, Jiao‐Feng Huang, Kenneth I. Zheng, Xiao‐Yan Pan, Hong‐Lei Ma, Wen‐Yue Liu, Christopher D. Byrne, Giovanni Targher, Yang‐Yang Li, Yong‐Ping Chen, Wah‐Kheong Chan, Ming‐Hua Zheng. Development and validation of a novel non‐invasive test for diagnosing fibrotic non‐alcoholic steatohepatitis in patients with biopsy‐proven non‐alcoholic fatty liver diseaseJournal of Gastroenterology and Hepatology 2020; 35(10): 1804 doi: 10.1111/jgh.15055
40
Jakub Morze, Manja Koch, Sarah A. Aroner, Matthew Budoff, Robyn L. McClelland, Kenneth J. Mukamal, Majken K. Jensen. Associations of HDL Subspecies Defined by ApoC3 with Non-Alcoholic Fatty Liver Disease: The Multi-Ethnic Study of AtherosclerosisJournal of Clinical Medicine 2020; 9(11): 3522 doi: 10.3390/jcm9113522
41
Ying Wang, Zishu Zeng, Lin Guan, Ran Ao. GRHL2 induces liver fibrosis and intestinal mucosal barrier dysfunction in non‐alcoholic fatty liver disease via microRNA‐200 and the MAPK pathwayJournal of Cellular and Molecular Medicine 2020; 24(11): 6107 doi: 10.1111/jcmm.15212
42
Vincenza Di Stasi, Elisa Maseroli, Giulia Rastrelli, Irene Scavello, Sarah Cipriani, Tommaso Todisco, Sara Marchiani, Flavia Sorbi, Massimiliano Fambrini, Felice Petraglia, Mario Maggi, Linda Vignozzi. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual DysfunctionFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.641446
43
Jia Peng, Ming-Ming Liu, Jing-Lu Jin, Ye-Xuan Cao, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Qian Dong, Jing Sun, Rui-Xia Xu, Jian-Jun Li. NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort studyLipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-021-01610-w
44
S. Marciano, M. Dirchwolf, M.C. Torres, J. Allevato, C. García Dans, B. García, F. Pollarsky, L. Gaite, E. Sirotinsky, B. Rios, M.N. Anselmo, M. Peche, E. Hurtado, L. Haddad, A. Narvaez, E. Mauro, A. Martinez, C. Bellizzi, N. Ratusnu, C. D́Amico, S. Arora, A. Gadano. Evaluación de fibrosis en pacientes con enfermedad por hígado graso no alcohólico: adherencia a los algoritmos propuestos y barreras para cumplir con ellosRevista de Gastroenterología de México 2022; 87(1): 4 doi: 10.1016/j.rgmx.2020.08.006
45
Zhijie Xu, Pengyuan He, Jianzhong Xian, Wuzhu Lu, Jingxian Shu, Wentao Luo, Chongjie Gan, Ruoman Ke, Jinyu Xia, Zongping Han, Mingxing Huang. Association between Nonalcoholic Fatty Liver Disease and Bone Mineral Density in HIV-Infected Patients Receiving Long-term TDF-Based Antiretroviral TherapyCurrent HIV Research 2021; 19(1): 40 doi: 10.2174/1570162X18999200917120449
46
Zobair M. Younossi, Mazen Noureddin, David Bernstein, Paul Kwo, Mark Russo, Mitchell L. Shiffman, Ziad Younes, Manal Abdelmalek. Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel RecommendationsAmerican Journal of Gastroenterology 2021; 116(2): 254 doi: 10.14309/ajg.0000000000001054
47
Stergios Kechagias, Mattias Ekstedt, Christian Simonsson, Patrik Nasr. Non-invasive diagnosis and staging of non-alcoholic fatty liver diseaseHormones 2022; 21(3): 349 doi: 10.1007/s42000-022-00377-8
48
Jingrui Wang, Zhenzhen Su, Yijin Feng, Ruihan Xi, Jiamin Liu, Peixi Wang. Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern ChinaBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02072-1
49
Yaqi Guan, Yilun Xu, Huang Su, Xuecheng Sun, Yanxuan Li, Tingting Wang. Effect of serum vitamin D on metabolic associated fatty liver disease: a large population-based studyScandinavian Journal of Gastroenterology 2022; 57(7): 862 doi: 10.1080/00365521.2022.2039284
50
Mazen Noureddin, Fady Ntanios, Deepa Malhotra, Katherine Hoover, Birol Emir, Euan McLeod, Naim Alkhouri. Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017–2018 transient elastography data and application of machine learningHepatology Communications 2022; 6(7): 1537 doi: 10.1002/hep4.1935
51
Nuria Perez-Diaz-del-Campo, Bertha Araceli Marin-Alejandre, Irene Cantero, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, Itziar Abete, M. Angeles Zulet. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) StudyEuropean Journal of Nutrition 2021; 60(6): 3043 doi: 10.1007/s00394-020-02476-x
52
Stefania Di Mauro, Alessandra Scamporrino, Agnese Filippello, Antonino Di Pino, Roberto Scicali, Roberta Malaguarnera, Francesco Purrello, Salvatore Piro. Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLDInternational Journal of Molecular Sciences 2021; 22(21): 11905 doi: 10.3390/ijms222111905
53
Yuting Ma, Chengxia Kan, Hongyan Qiu, Yongping Liu, Ningning Hou, Fang Han, Junfeng Shi, Xiaodong Sun. Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver DiseaseFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.793586
54
FaisalA Alsaif, SaraH Alqahtani, AmaniM Alsadoon, KhalidA Alswat, AymanA Abdo, MazenM Hassanain, AbdulsalamB Alsharabi, GhadeerR Aljuhani, HishamM Alkhalidi, MohammadS Elsharkawy, MaramA Alotaibi, FaisalM Sanai, WaleedK Al-hamoudi. Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone diseaseSaudi Journal of Gastroenterology 2020; 26(4): 204 doi: 10.4103/sjg.SJG_29_20
55
Matthias Ocker. Challenges and opportunities in drug development for nonalcoholic steatohepatitisEuropean Journal of Pharmacology 2020; 870: 172913 doi: 10.1016/j.ejphar.2020.172913
56
Antonella Mosca, Nadia Panera, Annalisa Crudele, Anna Alisi. Noninvasive diagnostic tools for pediatric NAFLD: where are we now?Expert Review of Gastroenterology & Hepatology 2020; 14(11): 1035 doi: 10.1080/17474124.2020.1801413
57
Andrej Hari. Ultrasound Elastography—Cornerstone of Non-Invasive Metabolic Dysfunction-Associated Fatty Liver Disease AssessmentMedicina 2021; 57(6): 516 doi: 10.3390/medicina57060516
58
Weijian Hang, Hongyang Shu, Zheng Wen, Jinyan Liu, Zhiyuan Jin, Zeqi Shi, Chen Chen, Dao Wen Wang. N-Acetyl Cysteine Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Intracellular Triglyceride Accumulation by Preserving Mitochondrial FunctionFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.636204
59
Segundo Moran. Prevalence of non alcoholic fatty liver disease and associated factors?Annals of Hepatology 2022; 27(2): 100659 doi: 10.1016/j.aohep.2022.100659
60
Solène Marie, David K.K. Tripp, Nathan J. Cherrington. Strategies to Diagnose Nonalcoholic Steatohepatitis: A Novel Approach to Take Advantage of Pharmacokinetic AlterationsDrug Metabolism and Disposition 2022; 50(4): 492 doi: 10.1124/dmd.121.000413
61
Ze Chen, Ruifeng Tian, Zhigang She, Jingjing Cai, Hongliang Li. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver diseaseFree Radical Biology and Medicine 2020; 152: 116 doi: 10.1016/j.freeradbiomed.2020.02.025
62
Jinying Xia, Guang Jin, Qifeng Hua, Shihan Cui, Jianhui Li. Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot StudyFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.917304
63
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLDInternational Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
64
Guotai Sheng, Song Lu, Qiyang Xie, Nan Peng, Maobin Kuang, Yang Zou. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver diseaseLipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01561-2
65
Grit Andersen, Leona Plum-Mörschel, Paul D. Hockings, Anni Morsing, Mads S. Palle, Olivia Svolgaard, Anne Flint. Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening DataAdvances in Therapy 2020; 37(12): 4866 doi: 10.1007/s12325-020-01503-x
66
A. Fabrizzio Bardales Silva. Enfermedad hepática grasa relacionada a trastornos metabólicosRevista Médica Basadrina 2022; 15(4): 85 doi: 10.33326/26176068.2021.4.1259
67
György Jermendy, Márton Kolossváry, Ibolya Dudás, Ádám L. Jermendy, Alexisz Panajotu, Imre F. Suhai, Zsófia D. Drobni, Júlia Karády, Ádám D. Tárnoki, Dávid L. Tárnoki, Szilard Voros, Béla Merkely, Pál Maurovich-Horvat. Effect of genetic and environmental influences on hepatic steatosis: A classical twin study based on computed tomographyImaging 2020; 12(1): 15 doi: 10.1556/1647.2020.00006
68
Chien-Chih Chen, Wei-Chien Hsu, Han-Ming Wu, Jiun-Yi Wang, Pei-Yu Yang, I-Ching Lin. Association between the Severity of Nonalcoholic Fatty Liver Disease and the Risk of Coronary Artery CalcificationMedicina 2021; 57(8): 807 doi: 10.3390/medicina57080807
69
Yen-Ying Chen, Matthew M. Yeh. Non-alcoholic fatty liver disease: A review with clinical and pathological correlationJournal of the Formosan Medical Association 2021; 120(1): 68 doi: 10.1016/j.jfma.2020.07.006
70
S. Marciano, M. Dirchwolf, M.C. Torres, J. Allevato, C. García Dans, B. García, F. Pollarsky, L. Gaite, E. Sirotinsky, B. Rios, M.N. Anselmo, M. Peche, E. Hurtado, L. Haddad, A. Narvaez, E. Mauro, A. Martinez, C. Bellizzi, N. Ratusnu, C. D’Amico, S. Arora, A. Gadano. Fibrosis assessment in patients with nonalcoholic fatty liver disease: Adherence to proposed algorithms and barriers to complying with themRevista de Gastroenterología de México (English Edition) 2022; 87(1): 4 doi: 10.1016/j.rgmxen.2021.09.002
71
Jonathan Mertens, Luc F. Van Gaal, Sven M. Francque, Christophe De Block. NAFLD in type 1 diabetes: overrated or underappreciated?Therapeutic Advances in Endocrinology and Metabolism 2021; 12: 204201882110555 doi: 10.1177/20420188211055557
72
Xiaonan Liu, Shuhong Chen, Lanju Zhang. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver diseaseAmerican Journal of Physiology-Endocrinology and Metabolism 2020; 319(1): E34 doi: 10.1152/ajpendo.00528.2019
73
Peng Huang, Biao Tu, Hui-jun Liao, Fei-zhou Huang, Zhen-zhou Li, Kuang-ye Zhu, Feng Dai, Huai-zheng Liu, Tian-yi Zhang, Chuan-zheng Sun. Elevation of plasma tRNA fragments as a promising biomarker for liver fibrosis in nonalcoholic fatty liver diseaseScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85421-0
74
Arash Akhavan Rezayat, Mohammad Ghasemi Nour, Yones Bondarsahebi, Seyyed Amin Hozhabrossadati, Fatemeh Amirkhanlou, Shima Akhavan Rezayat, Mohammadali Kiani, Bahareh Imani. The effects of melatonin therapy on the treatment of patients with Non-alcoholic steatohepatitis: A systematic review and Meta-analysis on clinical trial studiesEuropean Journal of Pharmacology 2021; 905: 174154 doi: 10.1016/j.ejphar.2021.174154
75
Salem Alsaqal, Paul Hockings, Håkan Ahlström, Anders Gummesson, Anders Hedström, Johannes Hulthe, Lars Johansson, Heiko G. Niessen, Corinna Schoelch, Christian Schultheis, Johan Vessby, Alkwin Wanders, Fredrik Rorsman, Charlotte Ebeling Barbier. The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis Journal of Magnetic Resonance Imaging 2022; 56(2): 368 doi: 10.1002/jmri.28040
76
Lei Zhang, Zhi-Gang She, Hongliang Li, Xiao-Jing Zhang. Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosisClinical Science 2020; 134(13): 1775 doi: 10.1042/CS20200446
77
Muharrem Bayrak. Non-invasive diagnosis of nonalcoholic fatty liver disease: impact of age and other risk factorsThe Aging Male 2020; 23(5): 1275 doi: 10.1080/13685538.2020.1763293
78
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, Giovanni Targher. NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and ManagementInternational Journal of Molecular Sciences 2019; 20(11): 2841 doi: 10.3390/ijms20112841
79
Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) StudyNutrients 2019; 11(10): 2359 doi: 10.3390/nu11102359
80
Weiyi Qu, Tengfei Ma, Jingjing Cai, Xiaojing Zhang, Peng Zhang, Zhigang She, Feng Wan, Hongliang Li. Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological StrategiesFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.761538
81
Minbo Zhang, Yu Zhang, Xiaoxiao Jiao, Linying Lai, Yiting Qian, Bo Sun, Wenzhuo Yang. Identification and validation of immune related core transcription factors GTF2I in NAFLDPeerJ 2022; 10: e13735 doi: 10.7717/peerj.13735
82
Eda Kaya, Yusuf Yilmaz. Obesity and Diabetes2020; : 321 doi: 10.1007/978-3-030-53370-0_24
83
Yuichiro Eguchi, Gabriel Wong, Omar Akhtar, Yoshio Sumida. Non‐invasive diagnosis of non‐alcoholic steatohepatitis and advanced fibrosis in Japan: A targeted literature reviewHepatology Research 2020; 50(6): 645 doi: 10.1111/hepr.13502
84
Monica Lupsor-Platon, Teodora Serban, Alexandra-Iulia Silion, Alexandru Tirpe, Mira Florea. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound ElastographyCancers 2020; 12(10): 2778 doi: 10.3390/cancers12102778
85
Haofei Hu, Yong Han, Changchun Cao, Yongcheng He. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese populationJournal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03611-4